# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-25-035755
Filing Date
2025-04-28
Accepted
2025-04-28 07:30:15
Documents
3
Period of Report
2025-06-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | ea0239291-def14a_citius.htm | DEF 14A | 146210
2 | GRAPHIC | image_001.jpg | GRAPHIC | 480585
3 | GRAPHIC | image_002.jpg | GRAPHIC | 358666
| Complete submission text file | 0001213900-25-035755.txt |  | 1303389

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 25875948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)